Across TCGA pan-cancer cohorts, LINC01935 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LINC01935’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where LINC01935 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01935 is over-expressed in tumor.
KIRP are the cancer types where LINC01935 tumor–normal differential expression is most reproducible.